Blue Owl Capital Holdings’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Blue Owl Capital Holdings’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,599,660	Closed	-$2.63M	–	49
2023 Q4	$2.63M	Buy	+1,599,660	New	+$25.2M	0.63%	27

Blue Owl Capital Holdings's ORTX Position: Q1 2024 in Review

Blue Owl Capital Holdings sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q1 2024, closing a stake of 1,599,660 shares — an estimated $2.63M sold.

Blue Owl Capital Holdings first reported a position in ORTX in Q4 2023 and held it in 1 quarter. The position peaked at $2.63M in Q4 2023. 0 funds tracked by Wall St. Rank hold ORTX as of Q1 2024.

Blue Owl Capital Holdings reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q1 2024 after selling out during the quarter.
Blue Owl Capital Holdings sold 1,599,660 Orchard Therapeutics plc American Depositary Shares shares in Q1 2024, an estimated $2.63M.
Blue Owl Capital Holdings first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2023 and held it in 1 quarter.
Blue Owl Capital Holdings's Orchard Therapeutics plc American Depositary Shares position peaked at $2.63M in Q4 2023.
0 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q1 2024.

Based on Blue Owl Capital Holdings's 13F filing for Q1 2024, filed 15 May 2024.